Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients

Clinical trial NCT00260234 · TERMINATED

Trial details

NCT number: NCT00260234
Sponsor: Novocell
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2005-11-01
Primary completion: 2007-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.